Información de la revista
Vol. 19. Núm. 8.
Páginas 408-409 (octubre 2001)
Vol. 19. Núm. 8.
Páginas 408-409 (octubre 2001)
Cartas al director
Acceso a texto completo
Infarto esplénico asociado con la presencia de inhibidor lúpico en un paciente con sida
Visitas
7140
Marcelo Corti, Norberto Trione, Kathy Corbera
Unidad 10. Hospital de Infecciosas F.J. Muñiz. Buenos Aires. Argentina
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
M. Greaves.
Antiphospholipid antibodies and trhrombosis.
Lancet, 353 (1999), pp. 1.348-1.353
[2.]
R.T. Canoso, L.I. Zon, J.E. Groopman.
Anticardiolipin antibodies associated with HTLV-III infection.
Br J Haematol, 65 (1987), pp. 495-498
[3.]
M.M. Stimmler, F.P. Jr Quismorio, W.G. McGehee, T. Boylen, O.P. Sharma.
Anticaridolipin antibodies in acquired immunodeficiency syndrome.
Arch Intern Med, 149 (1989), pp. 1.833-1.835
[4.]
W.B. Van Leeuwen, M.T. Jaroch, T.A. Broughan, R.E. Hermann.
The natural history of splenic infarction.
Surgery, 100 (1986), pp. 743-750
[5.]
J.H. Jr. O’Keefe, D.R. Jr Holmes, H.V. Schaff, P.F. II Sheedy, W.D. Edwards.
Thromboembolic splenic infarction.
Mayo Clin Proc, 61 (1986), pp. 967-972
[6.]
S. Mitchell, M.D. Cappel, D.O. Todd Simón, M.D. Moti Tiku.
Splenic infarction associated with anticardiolipin antibodies in a patient with acquired immunodeficiency syndrome.
Digestive Diseases and Sciences, 37 (1993), pp. 1.152-1.155
[7.]
T.P. Obarski, J.K. Stoller, C. Winstein, S. Hayden.
Splenic infaction: A new thrombotic manifestation of the circulating lupus anticoagulant.
Cleveland Clin J Med, 56 (1989), pp. 174-176
[8.]
J. Eldrup-Jorgensen, L. Brace, P. Flanigan, T.H. Schwarez, G. Fritsma, J.P. Meyer, et al.
Lupus-like anticoagulants and lower extremity arterial occlusive disease.
Circulation, 80 (1989), pp. 54-58
[9.]
S.R. Leviene, M.J. Deegan, N. Futrell, K.M.A. Welch.
Cerebrovasculr and neurologic disease associated with antiphospholipid antibodies: 48 cases.
Neurology, 40 (1990), pp. 1.181-1.189
[10.]
A.J. Cohen, T.M. Philips, C.M. Kessler.
Circulating coagulation inhibitors in the acquired immunodeficiency syndrome.
Ann Intern Med, 104 (1986), pp. 175-180
[11.]
M. Galli, P. Comfurius, C. Massen, H.C. Hemker, M.H. de Baets, P.J. van Bread-Vriesman, et al.
Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein factor.
Lancet, 355 (1990), pp. 1.544-1.547
[12.]
H.P. Mc Neil, J. Simpson, C.N. Chesterman, S.A. Krilis.
Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta-2-glycoprotein (apolipoprotein H).
Proc Nat Acad Sci USA, 87 (1990), pp. 4.120-4.124
[13.]
J. Coll, H. Yazbeck, J.M. Garces, A. Berges, F. Prats, J. Rubies-Prat.
Anticardiolipin antibodies and Pneumocystis carinii in patients with AIDS.
J Infect, 21 (1990), pp. 120
[14.]
S. Panzer, C. Stain, H. Hartl, R. Dudczak, K. Lechner.
Anticardiolipin antibodies are elevated in HIV-1 infected haemophilics but not predict for disease progression.
Thromb Hemost, 61 (1989), pp. 81-85
Copyright © 2001. Elsevier España, S.L.. Todos los derechos reservados